Please login to the form below

Not currently logged in
Email:
Password:

ALN-PCS

This page shows the latest ALN-PCS news and features for those working in and with pharma, biotech and healthcare.

Alnylam predicts big things for its PCSK9 inhibitor ALN-PCS

Alnylam predicts big things for its PCSK9 inhibitor ALN-PCS

ALN-PCSsc to eventually lead the market, despite trailing its rivals by several years. ... The success in the ongoing phase I trial means that clinical development of ALN-PCS is now taken over by The Medicines Company (TMC), which licensed rights to the

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics